Galecto Biotech AB
USPTO Trademark & Patent Filings
Trademark applications and grants for Galecto Biotech Ab. Galecto Biotech Ab has 1 trademark applications. The latest application filed is for "GALECTO"
- Company Aliases
- Galecto Biotech AB
- ab biotech galecto
- Galecto Biotech AB - Copenhagen DK
- GALECTO BIOTECH AB - Copenhagen DK
- GALECTO BIOTECH AB - COPENHAGEN DK
- GALECTO BIOTECH AB - Copenhagen N DK
| State Incorporated | SWEDEN |
| Entity Type | COMPANY |
| Address | Ole Maaløes Vej 3 Copenhagen SWEDEN 2200 |
Trademarks Patents
| Patent Application | Date |
|---|---|
| NOVEL GALACTOSIDE INHIBITOR OF GALECTINS 20220289783 - 17/748338 BRIMERT; Thomas ; et al. | 2022-09-15 |
| NOVEL GALACTOSIDE INHIBITOR OF GALECTINS 20220281909 - 17/624663 ZETTERBERG; Fredrik ; et al. | 2022-09-08 |
| NOVEL GALACTOSIDE INHIBITOR OF GALECTINS 20220259251 - 17/624730 ZETTERBERG; Fredrik | 2022-08-18 |
| ONCE-DAILY TREATMENT OF PULMONARY FIBROSIS 20220257628 - 17/736571 SCHAMBYE; Hans ; et al. | 2022-08-18 |
| LARGE SCALE PROCESS OF 3,3'-DIDEOXY-3,3'-BIS-[4-(3-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-1,1'-SUL- FANEDIYL-DI-BETA-D-GALACTOPYRANOSIDE 20220251132 - 17/622501 ZETTERBERG; Fredrik ; et al. | 2022-08-11 |
| Galactoside inhibitor of galectins 11,447,517 - 17/295,556 Zetterberg , et al. September 20, 2 | 2022-09-20 |
| Galactoside inhibitor of galectins 11,447,517 - 17/295,556 Zetterberg , et al. September 20, 2 | 2022-09-20 |
| Once-daily treatment of pulmonary fibrosis 11,406,655 - 15/572,660 Schambye , et al. August 9, 2 | 2022-08-09 |
| Once-daily treatment of pulmonary fibrosis 11,406,655 - 15/572,660 Schambye , et al. August 9, 2 | 2022-08-09 |
| Galactoside inhibitor of galectins 11,377,464 - 17/018,713 Brimert , et al. July 5, 2 | 2022-07-05 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"GALECTO" 90188961 |
GALECTO 2020-09-17 |
| NCAGE Code | AU39N | GALECTO BIOTECH AB |
| NCAGE Code | SUT88 | GALECTO BIOTECH AB |
| CAGE Code | SUT88 | GALECTO BIOTECH AB |
| CAGE Code | AU39N | GALECTO BIOTECH AB |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 